Natco Pharma reports 27% rise in Q3 consolidated net profit

16 Feb 2022 Evaluate

Natco Pharma has reported results for third quarter ended December 31, 2021.

The company has reported rise of 30.90% in its net profit at Rs 71.60 crore for the quarter under review as compared to Rs 54.70 crore for the same quarter in the previous year. Total income of the company increased by 57.70% at Rs 561.10 crore for Q3FY22 as compared Rs 355.80 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a rise of 26.81% in its net profit at Rs 80.40 crore for the quarter under review as compared to Rs 63.40 crore for the same quarter in the previous year. Total income of the company increased by 53.03% at Rs 590.70 crore for Q3FY22 as compared Rs 386.00 crore for the corresponding quarter previous year.

Natco Pharma Share Price

897.05 1.15 (0.13%)
30-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.60
Dr. Reddys Lab 1265.95
Cipla 1491.40
Zydus Lifesciences 901.30
Lupin 2081.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×